Author

Fabio Scianò

Amsterdam University Medical Centers

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Barbara ParrinoiD· 1 shared Camilla PecoraroiD· 1 shared Cecilia BergonziniiD· 1 shared Daniela CarboneiD· 1 shared Elisa GiovannettiiD· 1 shared Francesca Terrana· 1 shared Geng XuiD· 1 shared Girolamo CirrincioneiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Barbara ParrinoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Exploring the therapeutic potential of a novel series of imidazothiadiazoles targeting focal adhesion kinase (FAK) for pancreatic cancer treatment: Synthesis, mechanistic Insights and promising antitumor and safety profile

Camilla Pecoraro, Daniela Carbone, Fabio Scianò, Francesca Terrana, Geng Xu, Cecilia Bergonzini, Margot S. F. Roeten, Stella Cascioferro, Girolamo Cirrincione, Patrizia Diana, Elisa Giovannetti, Barbara Parrino

This study identifies compound 10l as a potent FAK inhibitor with antitumor activity and safety in pancreatic cancer models.

Journal of drug targeting · Jul 27, 2024Peer-reviewedCancer Biology